COVID 19: Drug Delivery Options to Succeed Sooner

The COVID-19 pandemic created an urgent imperative to find effective treatment options and vaccines and bring them to market safely and rapidly. This webinar reviews options for therapeutic and vaccine treatment strategies based on nasal and injectable drug development. The rationale for drug delivery targets in the upper and lower airways is discussed along with the selection of appropriate device platforms and the impact of device choice on formulation development. Injectable options are also explored and advice is provided on how to select the best packaging configuration; Aptar Pharma’s coated elastomer offering for injectables is presented. As the go-to expert in drug delivery, Aptar Pharma has been able to leverage therapeutic insights, regulatory expertise and a wide portfolio of systems and services to accelerate and derisk our customer’s drug development processes, thereby helping to improve and save patient lives.